Clinical Trial

Antibiotics and Vaccine Immune Responses Study

Study acronym: AVIRS
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to examine immune responses to the BCG vaccine in healthy adults who have, or who have not, taken antibiotics to deplete their gut bacteria prior to vaccination. The main question it aims to answer is: does depletion of the gut microbiota lead to impaired BCG-induced protection against specific and non-specific to challenges to the immune system?
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-17; most recent amendment 2025-12-03.
Trial Details
NCT Number NCT06148025
Lead Sponsor South Australian Health and Medical Research Institute
Collaborators: Royal Adelaide Hospital, Flinders University, University of Sydney, Telethon Kids Institute, Centenary Institute
Conditions Vaccine Response Impaired
Enrollment 348 participants
Start Date 2023-11-23
Primary Completion 2027-10-01 (estimated)
Study Completion 2028-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-10